Albumin, Behcet's Disease, Disease Severity, Lactate Dehydrogenase
Conditions
Brief summary
ABSTRACT Objective: To investigate whether the lactate dehydrogenase to albumin ratio can be used as a parameter to determine disease severity in Behçet's disease, an inflammatory disease, by comparing it to healthy controls. Patients and Methods: In this retrospective cohort study, patients with Behçet's disease aged 18-69 years who presented to the outpatient clinic between February 2020 and April 2023 and healthy individuals of similar age and gender were enrolled. LDH, albumin levels, and LDH/albumin ratio of both groups were compared. Clinical findings and characteristics of Behçet's patients and disease severity were recorded and analyzed in relation to LDH/albumin ratio.
Interventions
DIAGNOSTIC_TESTLDH/albumin ratio
LDH/Albumin ratios of patient and control groups were recorded.
Sponsors
Ataturk University
Study design
Observational model
COHORT
Time perspective
CROSS_SECTIONAL
Eligibility
Sex/Gender
ALL
Age
18 Years to 69 Years
Healthy volunteers
Yes
Inclusion criteria
Patients with Behçet's disease aged 18-69
Exclusion criteria
* younger than 18 years or older than 69 years, pregnant and lactating patients, patients with acute infection on admission or nutritional problems, symptomatic gastrointestinal symptoms, malignancy, hepatitis or liver disease were excluded.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| LDH/albumin ratio | February 2020 and April 2023 |
Countries
Turkey (Türkiye)
Outcome results
None listed